Chigusa Morizane

9.2k total citations · 1 hit paper
236 papers, 4.6k citations indexed

About

Chigusa Morizane is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chigusa Morizane has authored 236 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Oncology, 91 papers in Surgery and 68 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chigusa Morizane's work include Pancreatic and Hepatic Oncology Research (99 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (74 papers) and Neuroendocrine Tumor Research Advances (48 papers). Chigusa Morizane is often cited by papers focused on Pancreatic and Hepatic Oncology Research (99 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (74 papers) and Neuroendocrine Tumor Research Advances (48 papers). Chigusa Morizane collaborates with scholars based in Japan, United States and United Kingdom. Chigusa Morizane's co-authors include Takuji Okusaka, Masafumi Ikeda, Hideki Ueno, Junji Furuse, Shunsuke Kondo, Makoto Ueno, Hiroshi Ishii, Yoriko Takezako, Hideki Ueno and Kazuaki Shimada and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Chigusa Morizane

216 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study

2019 247 citations Makoto Ueno, Masafumi Ikeda et al. profile →

Peers

Countries citing papers authored by Chigusa Morizane

Since Specialization

Citations

This map shows the geographic impact of Chigusa Morizane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chigusa Morizane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chigusa Morizane more than expected).

Fields of papers citing papers by Chigusa Morizane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chigusa Morizane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chigusa Morizane. The network helps show where Chigusa Morizane may publish in the future.

Co-authorship network of co-authors of Chigusa Morizane

This figure shows the co-authorship network connecting the top 25 collaborators of Chigusa Morizane. A scholar is included among the top collaborators of Chigusa Morizane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chigusa Morizane. Chigusa Morizane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma 2025 ·Hepatology Research ·(unknown), Chigusa Morizane, Hiroyuki Isayama, (unknown), Masato Endo, Noritoshi Kobayashi, Yasushi Kojima, Shoji Kubo, Saburo Matsubara, Takeshi Shiraishi, Takashi Ohta, Tadashi Uwagawa, (unknown), (unknown), Setsuo Funasaka, Hiroki Ikezawa, Takuji Okusaka	1
2	Chondrosarcoma in Japan: an analytic study using population-based National Cancer Registry 2025 ·Japanese Journal of Clinical Oncology ·Hiroya Kondo, Koichi Ogura, Chigusa Morizane, (unknown), Shintaro Iwata, Yu Toda, (unknown), (unknown), Eisuke Kobayashi, Takahiro Higashi, Akira Kawai	0
3	Epidemiology and Outcomes of Retroperitoneal Sarcoma: An Analysis of the Population‐Based Cancer Registry in Japan 2016–2019 2025 ·Journal of Surgical Oncology ·(unknown), Koichi Ogura, Chigusa Morizane, (unknown), Shintaro Iwata, Yu Toda, (unknown), Hiroya Kondo, Eisuke Kobayashi, Takahiro Higashi, Akira Kawai	0
4	Incidence and factors associated with stent dysfunction and pancreatitis after gastroduodenal stenting for malignant gastric outlet obstruction 2024 ·SHILAP Revista de lepidopterología ·(unknown), Susumu Hijioka, Yoshikuni Nagashio, Yuta Maruki, (unknown), (unknown), Kohei Okamoto, (unknown), (unknown), (unknown), (unknown), (unknown), Akihiro Ohba, Shunsuke Kondo, Chigusa Morizane, Hideki Ueno, Miyuki Sone, Yutaka Saito, Takuji Okusaka	2
5	Sedative effects of propofol and risk factors for excessive sedation in the endoscopic treatment of biliary and pancreatic diseases 2024 ·SHILAP Revista de lepidopterología ·Yuta Maruki, Susumu Hijioka, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yoshikuni Nagashio, Chigusa Morizane, Miyuki Sone, Takuji Okusaka, Yutaka Saito	3
6	Statistics of Visceral Sarcoma in Japan: Report From the Population‐Based National Cancer Registry (NCR) in Japan 2024 ·Journal of Surgical Oncology ·(unknown), Koichi Ogura, Chigusa Morizane, (unknown), Yu Toda, Shintaro Iwata, Eisuke Kobayashi, Takahiro Higashi, Masahiko Ikeuchi, Akira Kawai	1
7	Study Protocol for a Prospective Self-Controlled Trial on Success in Meeting Comprehensive Genomic Profiling Analysis Criteria for Specimens Obtained by Endoscopic Ultrasound-Guided Tissue Acquisition Using a 19G Needle from Primary and Metastatic Lesions in Pancreatic Cancer with Metastatic Lesions: The PRIMATE Study 2024 ·SHILAP Revista de lepidopterología ·(unknown), Susumu Hijioka, Yoshikuni Nagashio, (unknown), (unknown), Yuki Kawasaki, (unknown), (unknown), (unknown), Kohei Okamoto, (unknown), (unknown), (unknown), (unknown), (unknown), Yuta Maruki, Chigusa Morizane, Hideki Ueno, Yasushi Yatabe, Takuji Okusaka	0
8	Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019 2024 ·Japanese Journal of Clinical Oncology ·Koichi Ogura, Chigusa Morizane, (unknown), Shintaro Iwata, Yu Toda, (unknown), (unknown), Hiroya Kondo, Eisuke Kobayashi, (unknown), Takahiro Higashi, Akira Kawai	3
9	Efficacy of hemostasis by gastroduodenal covered metal stent placement for hemorrhagic duodenal stenosis due to pancreatobiliary cancer invasion: a retrospective study 2024 ·Clinical Endoscopy ·Yasunari Sakamoto, Taku Sakamoto, Akihiro Ohba, Mitsuhito Sasaki, Shunsuke Kondo, Chigusa Morizane, Hideki Ueno, Yutaka Saito, Yasuaki Arai, Takuji Okusaka	0
10	A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy 2024 ·Clinical Cancer Research ·Junji Furuse, Masafumi Ikeda, Makoto Ueno, (unknown), Chigusa Morizane, Tetsuo Takehara, Tomohiro Nishina, Akiko Todaka, Naohiro Okano, Kazuo Hara, Yousuke Nakai, Kazuyoshi Ohkawa, Takashi Sasaki, Kazuya Sugimori, Naoyuki Yokoyama, Kouji Yamamoto	10
11	Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis 2023 ·Internal Medicine ·(unknown), Takuji Okusaka, Yuta Maruki, Akihiro Ohba, Yoshikuni Nagashio, Shunsuke Kondo, Susumu Hijioka, Chigusa Morizane, Hideki Ueno, Aoi Sukeda, (unknown), Takeshi Takamoto, Satoshi Nara, Daisuke Ban, Minoru Esaki, Nobuyoshi Hiraoka, Kazuaki Shimada	0
12	1203P Role of tumor markers before or during chemotherapy for poorly differentiated neuroendocrine carcinomas of the digestive system: An exploratory analysis of JCOG1213 2023 ·Annals of Oncology ·(unknown), Chigusa Morizane, Nozomu Machida, Yoshitaka Honma, Takuji Okusaka, Narikazu Boku, Ken Kato, Gakuto Ogawa, Y. Sano, Hiroshi Imaoka, Satoshi Kobayashi, Takeshi Terashima, Masafumi Ikeda, Naohiro Okano, Kensei Yamaguchi, Tosiya Sato, Nobumasa Mizuno, Yuko Kitagawa, Masanori Terashima, Makoto Ueno	1
13	Anticancer Effects of Fucoxanthin in a PDX Model of Advanced Stage Pancreatic Cancer with Alteration of Several Multifunctional Molecules 2023 ·SHILAP Revista de lepidopterología ·Masaru Terasaki, (unknown), Takuji Tanaka, H. Maeda, Masaki Shibata, Kazuo Miyashita, Yasuhiro Kuramitsu, Junichi Hamada, Tohru Ohta, Shigehiro Yagishita, Akinobu Hamada, Yasunari Sakamoto, Susumu Hijioka, Chigusa Morizane, Mami Takahashi	1
14	Endoscopic Ultrasound-Guided Tissue Acquisition of Pancreaticobiliary Cancer Aiming for a Comprehensive Genome Profile 2023 ·Diagnostics ·Susumu Hijioka, Yoshikuni Nagashio, Yuta Maruki, Yuki Kawasaki, (unknown), Chigusa Morizane, Takuji Okusaka	8
15	Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan 2023 ·Pancreatology ·(unknown), Chigusa Morizane, Noriko Tanabe, (unknown), Yuta Maruki, Akihiro Ohba, Yoshikuni Nagashio, Shunsuke Kondo, Susumu Hijioka, Hideki Ueno, Teruhiko Yoshida, Takuji Okusaka	6
16	Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors 2022 ·Japanese Journal of Clinical Oncology ·Izumi Komoto, Norihiro Kokudo, Taku Aoki, Chigusa Morizane, Tetsuhide Ito, Takuya Hashimoto, Wataru Kimura, Naoya Inoue, Kiyoshi Hasegawa, Shunsuke Kondo, Hideki Ueno, Hisato Igarashi, Takamasa Oono, Masatoshi Makuuchi, Takeshi Takamoto, Ichiro Hirai, (unknown), Masayuki Imamura	4
17	Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors 2022 ·Cancer Science ·Toshihiko Doi, Kohei Shitara, Takashi Kojima, Yasutoshi Kuboki, Nobuaki Matsubara, Hideaki Bando, Kiyotaka Yoh, Yoichi Naito, Hiroshi Hirai, Yukinori Kurokawa, Terufumi Kato, Chigusa Morizane	23
18	Hydrocolloid dressing as a prophylactic use for hand–foot skin reaction induced by multitargeted kinase inhibitors: protocol of a phase 3 randomised self-controlled study 2020 ·BMJ Open ·Sadamoto Zenda, (unknown), Atsuo Takashima, (unknown), Yusuke Takagi, Tempei Miyaji, (unknown), Yoichi Shimizu, Naoya Yamazaki, Chigusa Morizane, Takuhiro Yamaguchi, Takashi Kawaguchi, Akiko Hanai, Yosuke Uchitomi, (unknown)	2
19	Transarterial (Chemo)Embolization for Liver Metastases in Patients with Neuroendocrine Tumors 2017 ·Oncology ·Hiroyuki Okuyama, Masafumi Ikeda, Hideaki Takahashi, Izumi Ohno, Yusuke Hashimoto, Shuichi Mitsunaga, Yasunari Sakamoto, Shunsuke Kondo, Chigusa Morizane, Hideki Ueno, Tatsushi Kobayashi, Yasuaki Arai, Takuji Okusaka	10
20	Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment 2017 ·Oncology ·(unknown), Shunsuke Kondo, Akihiro Ohba, Mitsuhito Sasaki, Yasunari Sakamoto, Chigusa Morizane, Hideki Ueno, Takuji Okusaka	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact